Prnewswire.com / Pharmaceutical



Domain overview in Pharmaceutical niche. Based on relevant links and pages only.
prnewswire.com rank
92
Number of domains linking to prnewswire.com
17
semantic flow
3.72
Number of links to prnewswire.com
58
semantic flow
3.72
Number of domains linked from prnewswire.com
3
semantic flow
0.28
Number of links from prnewswire.com
4
semantic flow
0.28

Popular pages pointing to prnewswire.com

Pages with highest topical PageRank pointing to domain.

url / atext / target url
http://www.mallinckrodt.com/about/news-and-media/2178357
http www prnewswire com news releases mallinckrodt donates one million drug deactivation pouches to support us fight a
http://www.prnewswire.com/news-releases/mallinckrodt-donates-one-million-drug-deactivation
www.mallinckrodt.com
https://www.prnewswire.com/news-releases/merrimack-receives-orphan-drug-designation-for-mm
merrimack pharmaceuticals inc
https://www.prnewswire.com/news/merrimack-pharmaceuticals-inc
https://www.prnewswire.com/news-releases/merrimack-receives-orphan-drug-designation-for-mm
merrimack announces appointment of george demetri m d to board
https://www.prnewswire.com/news-releases/merrimack-announces-appointment-of-george-demetri
https://www.prnewswire.com/news-releases/merrimack-receives-orphan-drug-designation-for-mm
merrimack reports third quarter 2017 financial results
https://www.prnewswire.com/news-releases/merrimack-reports-third-quarter-2017-financial-re
https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-affirms-development-pathw
all videos
https://www.prnewswire.com/news-releases/videos/videos-list/
https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-affirms-development-pathw
mar 10 2016 06 17 et preview juniper pharmaceuticals reports fourth quarter and full year 2015 financial
https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-reports-fourth-quarter-an
https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-affirms-development-pathw
surveys polls and research
https://www.prnewswire.com/news-releases/general-business-latest-news/surveys-polls-and-re
https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-affirms-development-pathw
bond stock ratings
https://www.prnewswire.com/news-releases/financial-services-latest-news/bond-stock-ratings
https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-affirms-development-pathw
juniper pharmaceuticals reports third quarter 2017 financial and
https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-reports-third-quarter-201
https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-affirms-development-pathw
juniper pharmaceuticals to report third quarter 2017 results on
https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-to-report-third-quarter-2

Popular pages from prnewswire.com

On-topic pages from domain with highest topical PageRank.

title / url
PR


info
relevance


info
links


info
rel links


info
external links


info
external domains


info
referring domains


info
external backlinks


info
Merrimack Receives Orphan Drug Designation for MM-121 for the Treatment of Heregulin Positive
https://www.prnewswire.com/news-releases/merrimack-receives-orphan-drug-designation-for-mm
0.280.62294804411
Juniper Pharmaceuticals Affirms Development Pathway for Oxybutynin Intra-vaginal Ring for
https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-affirms-development-pathw
0.280.93296854411
Medimetriks Pharmaceuticals, Inc. Receives FDA Approval for Xepi™ (ozenoxacin) Cream, 1%, a Novel
https://www.prnewswire.com/news-releases/medimetriks-pharmaceuticals-inc-receives-fda-appr
0.280.78291772211

Popular prospect pages from prnewswire.com

On-topic pages from domain with highest topical PageRank having a few outgoing links and domains.

title / url
PR


info
relevance


info
links


info
rel links


info
external links


info
external domains


info
referring domains


info
external backlinks


info
Merrimack Receives Orphan Drug Designation for MM-121 for the Treatment of Heregulin Positive
https://www.prnewswire.com/news-releases/merrimack-receives-orphan-drug-designation-for-mm
0.280.62294804411
Juniper Pharmaceuticals Affirms Development Pathway for Oxybutynin Intra-vaginal Ring for
https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-affirms-development-pathw
0.280.93296854411

Domains with most semantic flow to prnewswire.com

Relevant domains with most links to selected domain.

domain info
count


info
semantic flow


info
http://juniperpharma.com/ 151.05juniperpharma.com
http://acelrx.com/ 110.81acelrx.com
http://ionispharma.com/ 120.69ionispharma.com
http://titanpharm.com/ 30.21titanpharm.com
http://drugchannels.net/ 30.14drugchannels.net
http://mallinckrodt.com/ 20.13mallinckrodt.com
http://westpharma.com/ 20.1westpharma.com
http://mediaroom.com/ 10.08mediaroom.com
http://merrimackpharma.com/ 10.07merrimackpharma.com
http://wikipedia.org/ 10.07wikipedia.org

Domains with most semantic flow from prnewswire.com

Relevant domains with most links from selected domain.

domain info
count


info
semantic flow


info
http://financialcontent.com/ 20.16financialcontent.com
http://jobvite.com/ 10.08jobvite.com
http://prnasia.com/ 10.04prnasia.com

Hubs from prnewswire.com

Pages from domain with most likely on-topic outgoing links.

url
count


info
PR


info
score


info
semantic flow


info
relevance


info
on topic


info
links


info
rel links


info
external links


info
external domains


info
referring domains


info
external backlinks


info
https://www.prnewswire.com/news-releases/medimetriks-pharmaceuticals-inc-receives-fda-appr 760.280.885.770.78yes291772211
https://www.prnewswire.com/news-releases/consumer-technology-latest-news/consumer-technolo 100.150.880.06-1no-1-1-1-100
https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-affirms-development-pathw 90.280.870.790.93yes296854411
https://www.prnewswire.com/news-releases/merrimack-receives-orphan-drug-designation-for-mm 40.280.680.180.62yes294804411
https://www.prnewswire.com/news-releases/environment-latest-news/ 40.150.890.02-1no-1-1-1-100
https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-reports-fourth-quarter-an 20.180.790.10.77yes299868411

contact | terms | privacy
© 2018-2024 semanticjuice.com